Yet even today, doctors do not know the exact causes of many brain diseases, which remain complicated and confusing. Battling diseases such as Alzheimer’s and Parkinson's will require fundamental leaps in understanding.
At Columbia’s Zuckerman Institute, our researchers study how healthy nervous systems work to better understand sickness. Which genes help nerves to function properly? What molecules keep the brain working from moment to moment, and what happens when they go awry? How do systems in the brain communicate to give rise to the everyday activities of our minds, from decision making to memory formation?
Advances in fundamental knowledge about the brain today will lay the foundation for future innovations in treating and curing disease. Our work can further the goals of clinical researchers who target diseases of the brain and disorders of the mind, ranging from Alzheimer’s and Parkinson’s to schizophrenia and autism.
September 15, 2017
October 14, 2015
Columbia University’s David Goldstein, PhD, a pioneer in genetics and precision medicine, discussed developing targeted treatments that have fundamentally improved the lives of patients living with devastating brain diseases.
Seed the discoveries that make a difference.